Inter-rater reliability of CTCAE assessments with or without EORTC patient-reported outcome data in a mixed cancer population: a multinational, open-label, randomised controlled trial

The Lancet Oncology 2026 Open access

Read full text
Authors: Lisa M Wintner, Monika Sztankay, Hikmat Abdel-Razeq, Renad Hamdan-Mansour, Giovanni Caocci, Guillaume Mouillet, Yuichiro Kikawa, Nobuhiro Shibata, Manjunath Nookala Krishnamurthy, Amit Joshi, Rahul Krishnatry, Aditi Jain
+9 more Helle Pappot, Duška Petranović, Antonela Trobentar, Heike Schmidt, Susann Schulze, A. A. Tararykova, August Zabernigg, Johannes M Giesinger, Bernhard Holzner
DOI: 10.1016/s1470-2045(25)00679-5
Cited by: 9
References: 18

Fields of Study & Subjects

Lung Cancer Treatments and Mutations Reliability and Agreement in Measurement Breast Cancer Treatment Studies

Publication details

Journal / source
The Lancet Oncology
Publisher
Elsevier BV
Volume
27
Issue
2
Pages
233–242
Publication date
19 January 2026
Language
EN